Trial
NCT07197034
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Aardvark Therapeutics, Inc.
Collaborators
—
Condition
Hyperphagia
Intervention
ARD-101
Why stopped
Due to operational and regulatory considerations.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-30